Last update 08 May 2025

Belatacept biosimilar(Suzhou Alphamab)

Overview

Basic Info

Drug Type
Fc fusion protein, Biosimilar
Synonyms
Belatacept Biosimilar (Suzhou Alphamab Co., Ltd.), 贝拉西普生物类似药(苏州康宁杰瑞生物科技有限公司), 重组人CTLA-4变体Fc融合蛋白
+ [1]
Action
inhibitors
Mechanism
CD80 inhibitors(Cluster of differentiation 80 inhibitors), CD86 inhibitors(Cluster of differentiation 86 inhibitors)
Therapeutic Areas
Inactive Indication
Originator Organization
Active Organization
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rheumatoid ArthritisPhase 2
China
08 Nov 2019
Rheumatoid ArthritisPhase 2
China
08 Nov 2019
Renal transplant rejectionPhase 2
China
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
145
iqqcevnhvk(tqyrpemxko) = 疗效方面,KN019 5mg/kg联合MTX和KN019 10mg/kg联合MTX两个剂量组ACR20应答率显著优于安慰剂联合MTX urzokykpps (uyzqckjjpw )
Positive
30 Sep 2022
Methotrexate+Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free